Cannell Thomas R
- SEC CIK
- 0001637822
No open-market purchases or sales filed in the past year.
Current role at each company
- CARM Carisma Therapeutics Inc.President and CEOas of Mar 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cannell Thomas R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Cannell Thomas RPresident and CEO | SSale | −487.5K | $0.59 | −$287.6K | −42.0%672.4K after | 2 lots |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Cannell Thomas RPresident and CEO | SSale | −53.7K | $0.59 | −$31.7K | −8.9%553.1K after |